Introduction: When Should You Seek Diagnostic Testing?

If you experience sudden changes in your vision, it’s important to seek medical attention without delay. People who should consider diagnostic testing for retinal neovascularisation include those noticing distorted or wavy vision, especially when looking at straight lines such as door frames or window edges. You might also see a dark, gray, or empty spot in the center of your vision, or find that images appear blurred without clear reason.^[1][6]

Certain individuals are at higher risk and should be particularly vigilant about seeking regular eye examinations. If you have diabetes, especially if your blood sugar levels have been poorly controlled over time, you face increased risk. The same applies if you’re over 50 years of age and have been diagnosed with age-related macular degeneration. People with a history of retinal vein or artery blockages should also remain alert to vision changes.^[2][3]

Regular comprehensive eye exams that include dilation of your pupils are essential for early detection. During these exams, your eye doctor can spot warning signs before you notice any symptoms yourself. This is particularly important because the condition often develops silently and painlessly in its early stages. By the time you experience noticeable symptoms, damage may have already occurred that could have been prevented with earlier intervention.^[2]

Classic Diagnostic Methods for Identifying Retinal Neovascularisation

Diagnosing retinal neovascularisation begins with a thorough physical examination of your eyes. Your eye doctor will perform a dilated eye exam, where special drops are used to widen your pupils. This allows the doctor to examine the back of your eye more carefully, looking for signs of abnormal blood vessel growth or bleeding in the retina. During this examination, they may see a blister of fluid or blood that has leaked into the retina.^[6]

A critical part of the diagnostic process involves gonioscopy, a technique that allows your doctor to examine the angle where your iris meets your cornea. This is performed using a special lens placed on the eye along with a thick liquid that helps the lens make contact. Through gonioscopy, doctors can visualize tiny new blood vessels that cross over structural landmarks in your eye, revealing neovascularisation that might not be visible otherwise. These abnormal vessels appear as small tufts at the pupil margin or as fine, branching vessels approaching the angle of the eye.^[12][23]

New blood vessels in retinal neovascularisation look different from normal blood vessels in several important ways. They are thinner and have a meandering, curly growth pattern rather than the normal straight, branching pattern you’d see in healthy vessels. They also lack the structural integrity of normal vessels because they don’t have tight junctions—specialized connections between cells that normally prevent leakage. This is why these new vessels are so prone to bleeding and leaking fluid.^[12]

Optical Coherence Tomography (OCT)

One of the most valuable diagnostic tools is optical coherence tomography, often called OCT for short. This is a completely painless imaging procedure that doesn’t require any injections. Instead, it uses light waves to capture detailed, three-dimensional cross-sectional images of your retina, much like how an ultrasound creates images but with much higher resolution.^[6][19]

OCT is particularly useful because it can show the different layers of your retina in great detail, highlighting any abnormalities such as the presence of abnormal blood vessels or fluid accumulation. Your doctor can see whether a choroidal neovascular membrane—a collection of abnormal vessels—has formed, and can assess whether fluid has leaked under or into the retina. This information helps determine not only whether you have the condition but also how severe it is and whether treatment is working.^[19]

Fluorescein Angiography

Another important diagnostic test is fluorescein angiography. During this test, a special dye called fluorescein is injected into a vein in your arm. This dye travels through your bloodstream to the blood vessels in your eyes. As it circulates, photographs are taken that show the dye lighting up the vessels, clearly revealing areas where blood vessels are leaking fluid.^[6][19]

Fluorescein angiography is especially useful for distinguishing between different types of neovascularisation. Doctors can classify abnormal vessel membranes into different categories based on how they appear during this test. The test shows not just where the abnormal vessels are located, but also how actively they are leaking, which provides important guidance for treatment decisions.^[19]

Additional Imaging Techniques

In some cases, especially when dealing with specific underlying conditions, additional imaging may be needed. Fundus photography creates detailed photographs of the back of your eye, documenting the appearance of the retina and any abnormal vessels. If your doctor suspects that neovascularisation is present but can’t see it clearly with standard examination, an iris fluorescein angiogram may be performed. This specialized test helps visualize very small or early abnormal vessels on the iris that might otherwise be missed.^[23]

Understanding what caused the neovascularisation is also important for proper diagnosis and treatment. Your doctor will look for underlying conditions such as diabetic retinopathy, where high blood sugar has damaged the tiny blood vessels in your retina over time. They’ll check for signs of vein or artery blockages in your retina, or evidence of age-related macular degeneration. Each of these underlying conditions requires its own approach to management alongside treating the neovascularisation itself.^[2][3]

Diagnostics for Clinical Trial Qualification

When patients with retinal neovascularisation are being considered for enrollment in clinical trials, they typically undergo a more extensive and standardized set of diagnostic tests. These tests serve multiple purposes: they confirm the diagnosis with precision, establish a baseline measurement of the condition’s severity, and ensure that patients meet specific criteria defined by the trial protocol.^[4]

Clinical trials investigating treatments for retinal neovascularisation routinely use optical coherence tomography as a standard assessment tool. This allows researchers to measure specific features of the disease in a consistent way across all study participants. The OCT scans provide objective measurements of retinal thickness, the presence and extent of fluid accumulation, and the structural changes caused by abnormal blood vessel growth. These measurements can be repeated at regular intervals throughout the trial to track whether the experimental treatment is having an effect.^[4]

Fluorescein angiography is also commonly required for clinical trial participation. This test provides detailed information about the activity level of neovascularisation—in other words, how actively the abnormal vessels are growing and leaking. Researchers use this information to categorize patients into different groups based on disease severity or type, which helps ensure that trial results are interpreted correctly and that different patient groups receive appropriate treatment approaches.^[6]

Visual acuity testing, which measures how well you can see, is another standard requirement for clinical trials. This isn’t just a simple eye chart test. In trials, visual acuity is typically measured using standardized protocols that ensure results are precise and reproducible. These measurements establish how much vision you have at the start of the trial and allow researchers to determine whether the experimental treatment improves, stabilizes, or fails to help your vision over time.^[4]

Many clinical trials also require documentation of the underlying condition that caused the neovascularisation. If diabetes is the cause, for example, you might need blood tests to check your blood sugar control and kidney function. If age-related macular degeneration is involved, detailed imaging and classification of the type and stage of macular degeneration may be necessary. This comprehensive assessment ensures that trial participants are appropriately matched to the experimental treatment being studied.^[2][3]

Some trials investigating new treatments specifically look for patients whose neovascularisation involves elevated levels of vascular endothelial growth factor, or VEGF. This is a protein that stimulates the growth of new blood vessels. Testing might include analysis of fluid samples taken from the eye or measurement of VEGF-related markers in the blood. Understanding the role of VEGF in a patient’s disease helps researchers determine whether treatments that block this protein will be effective.^[4][6]

Throughout a clinical trial, participants undergo repeated diagnostic testing at scheduled intervals. This ongoing monitoring serves several purposes. It helps researchers understand whether the treatment is working, identify any unexpected side effects or complications, and gather the data needed to determine whether the experimental treatment should be approved for wider use. While this means more frequent appointments and testing than you might experience during routine care, this careful monitoring also means that any problems are caught quickly and addressed promptly.^[4]